Showing posts with label #DIAIndiaAM2012. Show all posts

Friday, November 2, 2012

#diaIndiaAM2012 Saturday, November 3 Pharma sessions in Hyderabad, India

DIA’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare

Nov 1 2012 8:30AM - Nov 4 2012 5:00PM | Hyderabad International Convention Center Novotel & HICC Complex (Near Hitec City) PO Bag 1101 Cyberabad Post Office Hyderabad 500081 India

Saturday, November 3, 2012

9:00AM - 10:30AM

Session 10: Lead Discovery

Session Chair(s):

Raman Govindarajan
Senior Vice President, Development & Translational Medicine
Jubilant Biosys, India

Speaker(s):

Impact of Structural Biology on Drug Discovery Ajith Kamat
Head, Strategic Research Partnership
Pfizer Ltd., India
Lead Identification and Optimization in Small Molecular Drug Discovery: SBDD Case Studies Vellarkad N. Viswanadhan
VP
Jubilant Biosys, India
Application of Parallel Medicinal Chemistry Strategies for Rapid and Efficient Optimization of Adenosine A1 Receptor Modulators Representative Invited
United States

9:00AM - 10:30AM

Session 11: Go to Investors

Session Chair(s):

R. B. Smarta
Founder and Managing Director
Interlink Marketing Consultancy Pvt. Ltd., India

Session 11: Go to Investors

Speaker(s):

Mergers or Partners D. A. Prasanna
Chairman and Managing Director
Ecron Acunova, Germany
Branding: An Essential Tool to Attract Investment Madeline Ducate, MPH,MS
Exec.VP Global Operations
Pharm-Olam International, United States
Funding and Investing in New Product Development Anil Kamath
Eli Lilly and Company, United States

9:00AM - 10:00AM

Session 12: Quality Management in Manufacturing

Session Chair(s):

Sunil Singhai
Vice President - Tech Transfer
Dr. Reddy's Laboratories, India

Session 12: Quality Management in Manufacturing

Speaker(s):

Potent Product Process and Facility Design Sunil Singhai
Vice President - Tech Transfer
Dr. Reddy's Laboratories, India
Quality Management Process in Faculty Development Vinay Nayak
President Technical
Alembic Pharmaceuticals, India
World Class Manufacturing- A Challenge and Opportunity for the India Pharma Industry Pushpinder Bindra
CEO
Zenith and Beyond, India
Case Study: Integration of Patient Needs, and Quality Requirements in Recent Times has Enforced Application of “Quality by Design (QbD)” and “Process Analytical Technology (PAT)” to development of Therapeutic Vaccines Nicholas Cappuccino, PhD,MBA
Global Head, Quality
Dr. Reddy's, United States

11:30AM - 1:00PM

Session 13: Evolving Roles of Personnel Involved in Clinical Trials — Panel Discussion

Session Chair(s):

Sam T Mathew
Process Lead-Medical Writing
Accenture Services, India

Speaker(s):

Ajit Nair
Global Head, Clinical Services
TATA Consultancy Services, India
Partha Chakraborty, MBA
Director/Head, Pharmacovigilance Center of Excellence
Cognizant, India
Shubhadeep Sinha, DrMed,MD
Medical Doctor
Clinical Research & Pharmacovigilance Consultant, India

11:30AM - 1:00PM

Session 14: Lean Six Sigma — Medical Writing

Session Chair(s):

Nimita Limaye, PhD
Vice President
Tata Consultancy Services, India
Helle Gawrylewski, MA
Senior Director, Regulatory Medical Writing
Janssen R&D Companies of J&J, United States

Session 14: Lean Six Sigma — Medical Writing

Speaker(s):

Panel Discussion: Thinking Lean in Medical Writing: Driving Change Paul P. Sokol, PhD
Director
Johnson & Johnson Prd., United States
Panel Discussion: Thinking Lean in Medical Writing: Driving Change Shashidhar Rao
Head Global Medical Affairs and HEOR, India Operations
Novartis Healthcare Pvt. Ltd., India
Offshoring Medical Writing: Lean Project Management Strategy Paul P. Sokol, PhD
Director
Johnson & Johnson Prd., United States
Offshoring Medical Writing: Lean Project Management Strategy Seema G. Gurbani
Assistant Manager, Medical Writing
Tata Consultancy Services, India
Improving the Sigma Level of Medical Writing Shashidhar Rao
Head Global Medical Affairs and HEOR, India Operations
Novartis Healthcare Pvt. Ltd., India
Improving the Sigma Level of Medical Writing Murthy Palli
Operations Manager
Novartis Healthcare, India

11:30AM - 1:00PM

Session 15: Personalized Medicine and Challenges ahead for Biomanufacturing in India

Session Chair(s):

Subir Basak
President
Jubilant Biosys, India

Session 15: Personalized Medicine and Challenges ahead for Biomanufacturing in India

Speaker(s):

Pharmacogenomics for Personalized Medicine: Optimizing use of Drug and Drug Combinations to Improve Patient Outcome Jugnu Jain
Director
Saarum Sciences, India
Quality Control, a Necessary Paradigm when 'Leaning Out' Operations, as Pharmaceutials Shift from the Blockbuster Model to Personalized gene Therapies and Gene-specific Small-molecule Treatments Swapnil Ballal
Quality Lead
Biocon, India
BioManufacturing in India Subir Basak
President
Jubilant Biosys, India

2:00PM - 3:30PM

Session 16: Pre-clinical Discovery and Development

Session Chair(s):

Vishwanath Iyer (Mahesh)
Head, Oncology Biometrics
Novartis Healthcare, India

Speaker(s):

Translational Approaches to Target Validation, Drug Action and Patient Response Characterization Raman Govindarajan
Senior Vice President, Development & Translational Medicine
Jubilant Biosys, India
Imaging as a Biomarker in Early Stage Development Smita Pandit
Director, Imaging Operations
Perceptive Informatics, India
Pharmacovigilence and Drug Safety Shwetha Kamath
Drug Safety Physician
Accenture, India

2:00PM - 3:30PM

Session 17: Scientific, Regulatory and Ethical Challenges in Advancing Personalized Medicine

Session Chair(s):

Carol Isaacson Barash
Adjunct Prof. Personalized Medicine, Regis College
Principal, Helix Health Advisors, United States

Session 17: Scientific, Regulatory and Ethical Challenges in Advancing Personalized Medicine

Speaker(s):

Realizing the Promise of Personalization through Health Care Mass Commercialization Sagar Kamarthi
Associate Professor
Northeastern University, United States
Regulatory Challenges for Molecular and Companion Diagnostics Jeffrey N. Gibbs, JD
Director
Hyman Phelps & McNamara, PC, United States
Ethical Issues in Individualized Health Care — Seeking Solutions in a Complex World Aamir Shaikh, MD
Founder
Assansa, India
Personalized Nutrition: Parallels from Personalized Medicine Emmanuelle Voisin, PhD
CEO and Principal
Voisin Consulting, France

2:00PM - 3:30PM

Session 18: Data and Semantic Interoperability in Personalized Medicine

Session Chair(s):

Nikhil Kumar
President
Applied Technology Solutions, Inc., United States

Session 18: Data and Semantic Interoperability in Personalized Medicine

Speaker(s):

Semantic Interoperability, Data and Personalized Medicine Nikhil Kumar
President
Applied Technology Solutions, Inc., United States
CDASH Standards Library Implementation Across Multiple EDC Systems and its Potential Benefits Sunish Raj
Manager, GRO
PAREXEL International, India
Harmonization of Clinical Data Standards Senthil Raja
Manager, Clinical DB Programming
PAREXEL International, India

4:30PM - 6:00PM

Session 19: Current Challenges in Clinical Development in India

Session Chair(s):

Viswanath Iyer (Mahesh), PhD
Head, Oncology Biometrics
Novartis Healthcare Pvt. Ltd., India

Session 19: Current Challenges in Clinical Development in India

Speaker(s):

Challenges in Conducting Clinical Trials in India: Sponsor's Perspective Bobby George, PhD
Asst. VP, Regulatory Affairs
Reliance Life Sciences, India
T. Balganesh
Distinguished Scientist Head of OSDD Unit
Council of Scientific and Industrial Research (CSIR), India
Current Ethics Related Challenges in Clinical Development in India Shoibal Mukherjee, MD,MS
Vice President, Medical
Quintiles, India

4:30PM - 6:00PM

Session 20: Therapeutics — Pharmacology and Applications in Personalise Medicine

Session Chair(s):

Vishwas Sovani
Revogenex, Inc., India

Session 20: Therapeutics — Pharmacology and Applications in Personalise Medicine

Speaker(s):

Personalised Medicine Pharmacological basis Vishwas Sovani
Revogenex, Inc., India
Therapeutic Applications of Personalized Medicine Mangesh S. Kulkarni, MD
Group Head, DS&E
Novartis Healthcare, India
Ready to Use Kits for Personalized Medicine Mukesh Agrawal
Vice President, CRL
Vimta Labs, India

4:30PM - 6:00PM

Session 21: Panel Discussion on Regulatory in Manufacturing

Sunday, October 28, 2012

DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare

There are only 4 days left to register for India’s most informative and dynamic meeting on the pharmaceutical industry!

DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare, being held at the Hyderabad International Convention Center Novotel & HICC Complex on November 1-4 is shaping up to be a ‘can’t-miss event.’

This 2012 conference will focus on the discovery, development, manufacturing and commercialization to generate ground-breaking approaches to personalized health care. We are proud to present Keynote Addresses from Paul Huckle, Senior Vice President, Global Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles.

For Rs9000.00 for 3 days you will network with global colleagues, hear from top leaders, and choose from over 26
interactive sessions. Click here to view the conference program with over 75 International & India industry leaders.

There are only a few days left to for DIA India’s 7th Annual Conference- we are looking forward to seeing you there!

For more information and group registrations please contact Manoj.Trivedi@diaindia.org or call +91.98.2058.7798.

Thursday, October 11, 2012

DIA INDIA 7th Annual Conference - November 1-4 Hyderabad

Listen to Paul Huckle & Adrian McKemey - Keynote Speakers at 7th Annual Conference

KEYNOTE SPEAKER 1

Paul Huckle
Senior Vice President
Global Regulatory Affairs
GlaxoSmithKline

KEYNOTE SPEAKER 2

Adrian McKemey
Practice Leader, Product Development
& Commercialization
Quintiles

The 7^th Annual Conference this year will begin with Keynote Addresses from Paul Huckle, Senior Vice President, Global Regulatory Affairs, GlaxoSmithKline and Adrian McKemey, Practice Leader, Product Development & Commercialization, Quintiles.

The three day conference through 25 sessions and 3 tutorials on the theme 'Innovative Strategies for Individualized Health Care' will bring together regulators and pharma professionals working in the discovery, development, manufacturing or commercialization fields, academicians working in the fields related to the healthcare industry, finance professionals working in the healthcare sector and patient advocacy groups.

To know more on the conference program here are a few session details.

Scientific, Regulatory and Ethical Challenges in Advancing Personalized Medicine

This session chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will discuss

Realizing the Promise of Personalization through Healthcare Mass Commercialization by Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering, Northeastern University, Boston
Regulatory Challenges for Molecular and Companion Diagnostics by Jeffrey N. Gibbs, Director
Hyman, Phelps & McNamara, P. C.
Ethical Issues in Individualized Health Care — Seeking Solutions in a Complex World by Aamir Shaikh, Founder Assansa
Personalized Nutrition: Parallels from Personalized Medicine by Emanuelle Voisin, CEO and Principal, Voisin Consulting

Therapeutics — Pharmacology and Applications in Personalise Medicine

This session chaired by Vishwas Sovani, Country Manager, Revogenex, Inc. will discuss

Personalised Medicine Pharmacological basis by Vishwas Sovani, Country Manager, Revogenex, Inc.
Therapeutic Applications of Personalized Medicine by Mangesh Kulkarni, Group Head, DS&E
Novartis Healthcare
Ready to use Kits for Personalized Medicine by Mukesh Agrawal, Vice President - CRL,
Vimta Labs

Personalized Precision Medicine: Regulatory, Financial and Ethical Challenges to Ensuring its Growth

This panel chaired by Carol Isaacson Barash, Principal, Helix Health Advisors, Adjunct Prof. Personalized Medicine, Regis College will consist of the following panelists

Jeffrey N. Gibbs, Director, Hyman, Phelps & McNamara, P. C.
Arun Mishra, Director, Global Regulatory Affairs, Asia-Pacific, Japan, Emerging Markets, GlaxoSmithKline
Shoibal Mukherjee, Vice President and Head, Asia Medical Sciences Group, Quintiles
Nandini K. Kumar, Former Deputy Director General, Sr. Grade Investigator NIH project, National Institute of Epidemiology
Femida Gwadry-Sridhar, Director, Health Informatics, Lawson Health Research Institute
Sagar Kamarthi, Associate Professor, Department of Mechanical and Industrial Engineering
Northeastern University, Boston

7^th Annual Conference Registration Fees Reduced

Registration fees at the 7^th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders.

For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.

Thank You to our 7^th Annual Conference Supporters

Level 2

Level 1

Email Preferences | My DIA | Forward to a Friend

Monday, October 8, 2012

Innovative Strategies for Individualized Health Care (Hyderabad) - last 3 wks to register

Last 3 Weeks To Register - 7th Annual Conference

The 7^th Annual Conference this year through 25 sessions and 3 tutorials on the theme 'Innovative Strategies for Individualized Health Care' will bring together regulators and pharma professionals working in the discovery, development, manufacturing or commercialization fields, academicians working in the fields related to the healthcare industry, finance professionals working in the healthcare sector and patient advocacy groups.
To know more on the conference program here are a few session details.

Lead Discovery
This session chaired by Raman Govindarajan, Head R&D, Sanofi will discuss

Impact of Structural Biology on Drug Discovery by Ajith Kamat, Head, Strategic Research Partnerships, Pfizer
Lead Identification and Optimization in Small Molecular Drug Discovery: SBDD Case Studies byVellarkad N. Viswanadhan, Vice President, Jubilant Biosys
Application of Parallel Medicinal Chemistry Strategies for Rapid and Efficient Optimization of Adenosine A1 Receptor Modulators by Venkata Palle, Vice President - Discovery Research
Novel Drug Discovery and Development, Lupin

Product and Pricing Strategy and Payor Challenges
This session chaired by R. B. Smarta, Founder and Managing Director, Interlink Marketing Consulting will discuss

Sizing the Opportunity, Market Driven Commercialization of Products by Dhananjay Bhakhle, Executive Vice President, Medical Research, Lupin Pharmaceuticals
Pricing Strategy in Indian Context by Anil Kamath, Founder Chairman, Esemcee Advisors
Using Real World Evidence to Drive Access Strategies by Simu Thomas, Global Head, Economic Modeling, Global Medical Affairs and HEOR Novartis, USA

Evolving Roles of Personnel Involved in Clinical Trials:
Panel Discussion
This panel chaired by Sam Mathew, Process Lead-Medical Writing, Accenture Services will consist of the following panelists

Ajit Nair, Global Head - Clinical Services, Tata Consultancy Services
Partha Chakraborthy, Senior Director & Global Delivery Head, R&D, Cognizant Technology Solutions
Anish Desai, Director Medical Affairs and Clinical Operations, Johnson & Johnson
S Sinha, Head (Global) & Associate Vice President, Clinical Development & Medical Affairs (CD&MA), Hetero Group

7^th Annual Conference Registration Fees Reduced
Registration fees at the 7^th Annual Conference have been reduced by nearly 20% to as low as Rs. 9,000 + taxes to help the industry participate in large numbers and gain immensely through this unique networking opportunity. Click here to view the conference program with over 75 International & India industry leaders.
For more information and group registrations please contact Rhean.DSouza@diaindia.org or call +91.98.2058.7798.
Follow us and tweet on the 7^th Annual Conference with #DIAIndiaAM2012

Life Science Items of Interest

Friday, November 2, 2012

#diaIndiaAM2012 Saturday, November 3 Pharma sessions in Hyderabad, India

DIA’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare

Sunday, October 28, 2012

DIA India’s 7th Annual Conference Discovery through Commercialization: Innovative Strategies for Individualized Healthcare

Thursday, October 11, 2012

DIA INDIA 7th Annual Conference - November 1-4 Hyderabad

Monday, October 8, 2012

Innovative Strategies for Individualized Health Care (Hyderabad) - last 3 wks to register

Follow us:

Total Pageviews